The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1‐ and I2‐sites

British Journal of Pharmacology

Volumn 112, Issue 4, 1994, Pages 1065-1070

  Chan, Susan L F ^a   Brown, Colin A ^a   Scarpello, Kay E ^a   Morgan, Noel G ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

down regulation; efaroxan; imidazoline; insulin secretion; Islets of Langerhans; I site; RINm5F cells; RX821002

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; CLONIDINE; DIAZOXIDE; EFAROXAN; IDAZOXAN; IMIDAZOLINE DERIVATIVE; PHENTOLAMINE; PRAZOSIN;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; INSULIN RELEASE; LANGERHANS CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION;

ANIMAL; BENZOFURANS; BINDING SITES; DIOXANES; DOWN-REGULATION; IMIDAZOLES; INSULIN; MALE; RATS; RATS, WISTAR; RECEPTORS, DRUG; SUPPORT, NON-U.S. GOV'T;

EID: 0027968398     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1994.tb13191.x     Document Type: Article

References (35)

1. Effects of α‐adrenoceptor blockade by phentolamine on basal and stimulated insulin secretion in the rat
2. Mechanism of galanin‐inhibited insulin release. Occurrence of a pertussis toxin‐sensitive inhibition of adenylate cyclase
3. Clonidine‐displacing substance (CDS) and its putative imidazoline receptor
4. Effect of imidazolines on sodium transport and intracellular pH in renal proximal tubule cells
5. Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non‐adrenoceptor idazoxan binding sites
6. 2‐adrenoceptors and imidazoline‐binding sites in the control of insulin secretion
7. 2‐adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site
8. ATP channels in insulin‐secreting cells
9. Effects of α‐adrenergic antagonists on insulin secretion from rat pancreatic islets
10. Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels
11. Mechanisms involved in stimulation of insulin secretion by the hypoglycaemic alpha‐adrenergic antagonist, DG‐5128
12. Block of ATP‐regulated potassium channels by phentolamine and other α‐adrenoceptor antagonists
13. 1‐imidazoline receptors
14. Maintenance of human normal cells in continuous culture: preliminary report; cultivation of mesoblastic tumors and normal cells and notes on methods of cultivation
15. Imidazolines stimulate insulin secretion from perfused rat pancreas
16. Down‐regulation of imidazoline sites in rabbit kidney
17. 2‐adrenoceptor sites
18. Evidence for differential effects of noradrenaline and somatostatin on intracellular messenger systems in rat islets of Langerhans
19. + channels in pancreatic β‐cells
20. 2‐adrenoceptors and of non‐adrenergic idazoxan binding sites in pancreatic islets from young and adult hamsters
21. 3H]‐RX821002: a new tool for the identification of α2A‐adrenoceptors
22. 3H] idazoxan label different populations of imidazoline sites on rat kidney
23. Keeping an eye on the I site: imidazoline‐preferring receptors
24. Pentitols and insulin release by isolated rat islets of Langerhans
25. 2‐receptor activation
26. 3H]‐idazoxan binding sites in the rat brain
27. Characterization of brain imidazoline receptors in normotensive and hypertensive rats: differential regulation by chronic imidazoline drug treatment
28. + channels in mouse pancreatic β‐cells
29. Regulation of immunoreactive‐insulin release from a rat cell line (RINm5F)
30. The insulin‐secreting cell line, RINm5F, expresses an alpha‐2D adrenoceptor and nonadrenergic idazoxan‐binding sites
31. Phentolamine, a deceptive tool to investigate sympathetic nervous control of insulin release
32. An insulin‐releasing property of imidazoline derivatives is not limited to compounds that block alpha‐adrenoceptors
33. 2‐adrenoceptors are blocked
34. Measurement of protein using bicinchoninic acid